Amit Bar‐Or
University of Pennsylvania(US)
Publications by Year
Research Areas
Multiple Sclerosis Research Studies, Immunotherapy and Immune Responses, Peripheral Neuropathies and Disorders, T-cell and B-cell Immunology, Neuroinflammation and Neurodegeneration Mechanisms
Most-Cited Works
- → B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis(2008)2,374 cited
- → Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis(2016)1,899 cited
- → Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis(2016)1,807 cited
- → Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis(2012)1,686 cited
- → Multiple sclerosis(2018)1,333 cited
- → IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases(2014)1,002 cited
- → Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study(2018)